Michael Christiano

Director, Revenue at Ardelyx

Speaker

Mr. Christiano has served as Ardelyx Inc’s Director, Revenue Accounting since November 2023. Prior to that, Mr. Christiano served as the Director, Revenue Finance at Biohaven Pharmaceuticals, which was acquired by Pfizer, where he was responsible for overseeing all aspects of the commercial revenue recognition. Earlier in his career, Mr. Christiano was the Director, Finance at Amring Pharmaceuticals (now Nordic Pharma Inc) and Assistant Controller at Amedra Pharmaceuticals (acquired by Impax Labs, now Amneal Pharmaceuticals).